Pretreatment regimen for high-risk patients receiving urographic contrast media.
Retrospective analysis of 85 high-risk patients, pretreated with prednisone who received urographic contrast media, was associated with no adverse effects in 76 (89.6%) procedures. Serious reactions were recorded only in 1 patient (1.1%). Based on the results, our regimen is an appropriate prophylaxis.